Skip to content

A registered clinical trial of comparison of influence on patients' left ventricular systolic synchrony by left bundle branch pacing versus right ventricular septum pacing

A registered clinical trial of comparison of influence on patients' left ventricular systolic synchrony by left bundle branch pacing versus right ventricular septum pacing: A single center prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037783
Enrollment
Unknown
Registered
2020-09-01
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Status after pacemaker implantation

Interventions

right ventricular septum pacing group:right ventricular septum pacing

Sponsors

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patient must be more than 18 years old; 2. Patients with the indication of permanent pacemaker implantation in our hospital, and with the diagnosis of sick sinus syndrome (SSS) with normal QRS duration (< 120 ms) at baseline or atrioventricular block (AVB) not completely dependent on pacing; 3. Patients implanted with dual-chamber pacemaker and with clear ultrasonic images for ventricular synchrony analysis; 4. Patients who have been successfully performed with left bundle branch pacing or right ventricular septum pacing. The criteria for successful implantation are shown in section 4.2 of the study protocol; 5. Patient is informed and has signed informed consent. Patient is willing to attend an outpatient follow-up.

Exclusion criteria

Exclusion criteria: 1. Heart failure due to any etiology; 2. Structural heart disease, including valvular heart disease, congenital heart disease, cardiomyopathy, etc; 3. Moderate to severe pulmonary hypertension caused by any disease; 4. Atrial fibrillation or frequent premature ventricular / atrial contraction bigeminy or trigeminy; 5. Active infection; 6. Patient with mentally ill; 7. Participation in another clinical trial, either within the past 2 months or still ongoing. 8. Pregnant women, breast-feeding, or of child-bearing potential; 9. Patients with poor compliance who cannot be followed up according to the study protocol by researcher's judgment; 10. Any other situation that the researcher considers the patient is unsuitable for participation in the trial.

Design outcomes

Primary

MeasureTime frame
peak strain dispersion;longitudinal systolic peak strain;

Secondary

MeasureTime frame
Pulmonary pressure;Degree of mitral valve regurgitation;Degree of tricuspid valve regurgitation;NYHA classification;NT-proBNP level;

Countries

China

Contacts

Public ContactGuosheng Fu

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

fugs@medmail.com.cn+86 13605800707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026